Catalog / agnopharma.com
66

SEO audit for agnopharma.com

Agno Pharma: Pharmaceutical CDMO & CMO - Formulation. Development. Commercialization

otherWordPress

Health 66/100 (fair) · 50 pages crawled · generated 2026-08-26

Download Markdown report (feed to ChatGPT / Claude / Cursor)

Agno Pharma: A leading Pharmaceutical CDMO & CMO in the US and China. We take your product from formulation, to development and manufacturing, to commercialization.

Screenshot of agnopharma.com
50
pages crawled
48
indexable pages
0
errors
175
warnings
330
notices
0
orphan pages
0
broken links
Category breakdown
CategoryScoreErrorsWarningsNotices
Links 68 0 54 3
Agent Readiness 71 0 48 12
Structured Data 84 0 26 2
Titles 87 0 22 0
Duplicate 90 0 17 0
Headings 95 0 8 5
Content 100 0 0 65
Crawlability 100 0 0 1
Images 100 0 0 8
Meta Description 100 0 0 8
Performance 100 0 0 126
Security 100 0 0 95
URL 100 0 0 5
Findings

Warnings (7 rules)

warning Control has no accessible name

Rule agent.control_no_name · Agent Readiness · 48 occurrence(s)

warning Duplicate page content

Rule duplicate.content · Duplicate · 8 occurrence(s)

warning Near-duplicate page content

Rule duplicate.near · Duplicate · 9 occurrence(s)

warning Missing <h1>

Rule h1.missing · Headings · 8 occurrence(s)

warning Internal link points to a redirect

Rule links.redirect_target · Links · 54 occurrence(s)

warning Schema describes content not visible on the page

Rule schema.hidden_content · Structured Data · 26 occurrence(s)

warning Title likely truncated in SERP (too wide)

Rule title.too_long · Titles · 22 occurrence(s)

Notices (23 rules)

notice Heading levels skip a level

Rule agent.heading_skip · Agent Readiness · 11 occurrence(s)

notice No llms.txt for AI agents

Rule agent.llms_txt_missing · Agent Readiness · 1 occurrence(s)

  • https://agnopharma.com/ — no llms.txt found at the site root — add one so AI agents get a curated site summary

notice Low text-to-HTML ratio

Rule content.low_ratio · Content · 17 occurrence(s)

notice Main text is hard to read (low Flesch Reading Ease)

Rule content.readability_poor · Content · 48 occurrence(s)

  • https://agnopharma.com/ — this page reads as very difficult (Flesch Reading Ease -41, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/about/ — this page reads as very difficult (Flesch Reading Ease -9, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/about/careers/ — this page reads as very difficult (Flesch Reading Ease -7, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/about/team/celia-l-alexander/ — this page reads as very difficult (Flesch Reading Ease -28, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/analytical-services/ — this page reads as very difficult (Flesch Reading Ease -74, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/analytical-services/capabilities/ — this page reads as very difficult (Flesch Reading Ease -74, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/analytical-services/capabilities/ich-stability-programs/ — this page reads as very difficult (Flesch Reading Ease -15, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/blog/beta-lactam-manufacturing-challenges/ — this page reads as very difficult (Flesch Reading Ease 28, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/blog/nanomilling-for-poorly-soluble-apis-the-mill-is-the-easy-part/ — this page reads as very difficult (Flesch Reading Ease 22, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/blog/scaling-up-pharmaceutical-production-for-successful-technology-transfer-in-sterile-dosage-forms/ — this page reads as very difficult (Flesch Reading Ease -4, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/blog/the-complete-guide-to-long-acting-injectable-lai-formulations/ — this page reads as very difficult (Flesch Reading Ease 29, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/category/blog/ — this page reads as very difficult (Flesch Reading Ease -71, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/contact-us/ — this page reads as very difficult (Flesch Reading Ease -39, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/drug-product/ — this page reads as very difficult (Flesch Reading Ease -74, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/drug-product/dosage-forms/ — this page reads as very difficult (Flesch Reading Ease -74, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/drug-product/manufacturing/cgmp-commercial/ — this page reads as very difficult (Flesch Reading Ease -13, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/event/podd-conference-boston-ma/ — this page reads as very difficult (Flesch Reading Ease -50, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/implants-lais/ — this page reads as very difficult (Flesch Reading Ease -74, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/implants-lais/manufacturing/ — this page reads as very difficult (Flesch Reading Ease -74, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/implants-lais/rd/polymeric-cryomilling/ — this page reads as very difficult (Flesch Reading Ease -23, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/intermediates-api/ — this page reads as very difficult (Flesch Reading Ease -74, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/intermediates-api/manufacturing/cgmp-commercial-manufacturing/ — this page reads as very difficult (Flesch Reading Ease -12, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/intermediates-api/rd/ — this page reads as very difficult (Flesch Reading Ease -74, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/news/particle-sciences-inc-and-delaqua-pharmaceuticals-announce-strategic-collaboration/ — this page reads as very difficult (Flesch Reading Ease -21, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.
  • https://agnopharma.com/technical-briefs/development-and-validation-of-in-vitro-release-testing-for-semisolid-formulations/ — this page reads as very difficult (Flesch Reading Ease 17, below 50) — long sentences and multi-syllable words make it hard to scan. Shorten sentences and prefer plainer words to widen your audience. Density can be legitimate for expert, technical or legal content, so judge it against who the page is for.

notice Title tag and meta description are identical

Rule content.title_meta_same · Meta Description · 1 occurrence(s)

notice Multiple <h1> elements

Rule h1.multiple · Headings · 5 occurrence(s)

notice Image alt text is keyword-stuffed (repetition / low variety)

Rule images.alt_stuffed · Images · 3 occurrence(s)

notice Image alt text is very long (possible keyword stuffing)

Rule images.alt_too_long · Images · 4 occurrence(s)

notice Image filename is generic/auto-generated (missed image-search signal)

Rule images.generic_filename · Images · 1 occurrence(s)

  • https://agnopharma.com/category/blog/ — 1 image(s) use a generic/auto-generated filename (e.g. IMG_1234.jpg, photo1.png, a bare UUID). Google reads the filename as a signal of image content, so rename files descriptively (hyphen-separated words) before upload.

notice Likely hero image lacks fetchpriority=high

Rule images.hero_no_fetchpriority · Performance · 30 occurrence(s)

  • https://agnopharma.com/ — the likely hero/LCP image (agno-logo-dark.svg) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/about/careers/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/about/team/celia-l-alexander/ — the likely hero/LCP image (agno-logo.svg) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/analytical-services/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/analytical-services/capabilities/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/analytical-services/capabilities/ich-stability-programs/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/blog/beta-lactam-manufacturing-challenges/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/blog/contract-pharmaceutical-manufacturing-industry-projections/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/blog/nanomilling-for-poorly-soluble-apis-the-mill-is-the-easy-part/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/blog/scaling-up-pharmaceutical-production-for-successful-technology-transfer-in-sterile-dosage-forms/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/blog/the-modern-cdmo/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/drug-product/ — the likely hero/LCP image (agno-logo.svg) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/drug-product/dosage-forms/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/event/podd-conference-boston-ma/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/implants-lais/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/implants-lais/manufacturing/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/implants-lais/rd/polymeric-cryomilling/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/intermediates-api/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/intermediates-api/manufacturing/cgmp-commercial-manufacturing/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/intermediates-api/rd/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/news/robert-w-lee-ph-d-to-present-on-advanced-nanocrystal-technology-at-november-2025-formulation-summit/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/technical-briefs/combination-devices/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/technical-briefs/development-and-validation-of-in-vitro-release-testing-for-semisolid-formulations/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/technical-briefs/emulsions-and-emulsifications/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.
  • https://agnopharma.com/technical-briefs/surfactants/ — the likely hero/LCP image (svg%3e) has no fetchpriority="high" — adding it tells the browser to fetch the hero earlier in the waterfall, reducing Largest Contentful Paint. This is a low-severity nudge; verify the flagged image is actually your LCP element.

notice Internal link has no anchor text / accessible name

Rule links.no_anchor_text · Links · 3 occurrence(s)

  • https://agnopharma.com/ — 4 internal link(s) have no anchor text, aria-label, or image alt — they pass no keyword signal and are unusable to screen readers. Add descriptive text or an aria-label.
  • https://agnopharma.com/category/blog/ — 90 internal link(s) have no anchor text, aria-label, or image alt — they pass no keyword signal and are unusable to screen readers. Add descriptive text or an aria-label.
  • https://agnopharma.com/drug-product/ — 1 internal link(s) have no anchor text, aria-label, or image alt — they pass no keyword signal and are unusable to screen readers. Add descriptive text or an aria-label.

notice Meta description too long

Rule meta_desc.too_long · Meta Description · 5 occurrence(s)

notice Meta description too short

Rule meta_desc.too_short · Meta Description · 2 occurrence(s)

notice Large DOM (over 1500 elements) slows rendering & interaction

Rule perf.dom_size_large · Performance · 1 occurrence(s)

  • https://agnopharma.com/category/blog/ — the page has 2570 DOM elements (recommended maximum is around 1500) — a large DOM increases style-recalculation, layout and paint cost, hurting LCP and INP. Flatten deep nesting, paginate long lists/tables, and lazy-render off-screen elements.

notice Legacy image format (jpg/png/gif) with no next-gen fallback

Rule perf.images_legacy_format · Performance · 47 occurrence(s)

notice No ETag header (no conditional GET for unchanged pages)

Rule perf.no_etag · Performance · 48 occurrence(s)

  • https://agnopharma.com/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/about/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/about/careers/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/about/team/celia-l-alexander/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/analytical-services/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/analytical-services/capabilities/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/analytical-services/capabilities/ich-stability-programs/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/blog/beta-lactam-manufacturing-challenges/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/blog/nanomilling-for-poorly-soluble-apis-the-mill-is-the-easy-part/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/blog/scaling-up-pharmaceutical-production-for-successful-technology-transfer-in-sterile-dosage-forms/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/blog/the-complete-guide-to-long-acting-injectable-lai-formulations/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/category/blog/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/contact-us/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/drug-product/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/drug-product/dosage-forms/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/drug-product/manufacturing/cgmp-commercial/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/event/podd-conference-boston-ma/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/implants-lais/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/implants-lais/manufacturing/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/implants-lais/rd/polymeric-cryomilling/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/intermediates-api/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/intermediates-api/manufacturing/cgmp-commercial-manufacturing/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/intermediates-api/rd/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/news/particle-sciences-inc-and-delaqua-pharmaceuticals-announce-strategic-collaboration/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.
  • https://agnopharma.com/technical-briefs/development-and-validation-of-in-vitro-release-testing-for-semisolid-formulations/ — the response carries no ETag header — without an ETag (or Last-Modified) there is no cache-revalidation mechanism, so crawlers re-download the full body every visit. Emit an ETag (a content hash) to enable conditional If-None-Match requests.

notice URL redirects to another URL

Rule redirect.single · Crawlability · 1 occurrence(s)

notice Deep page has no BreadcrumbList structured data

Rule schema.breadcrumb_missing · Structured Data · 1 occurrence(s)

notice Deprecated schema type with no Google rich result

Rule schema.deprecated_type · Structured Data · 1 occurrence(s)

  • https://agnopharma.com/ — deprecated rich-result type(s) present: Sitelinks Searchbox. The markup is valid schema.org but Google no longer generates a rich result for it — remove or repurpose the block.

notice Missing recommended security headers

Rule security.missing_headers · Security · 48 occurrence(s)

notice target=_blank link without rel=noopener (tab-napping)

Rule security.unsafe_cross_origin_links · Security · 47 occurrence(s)

notice URL is very long

Rule url.too_long · URL · 4 occurrence(s)

notice Uppercase letters in URL path

Rule url.uppercase · URL · 1 occurrence(s)

Pages (showing 50 of 50)
URLStatusIndexableWordsIn-links
https://agnopharma.com/
Agno Pharma: Pharmaceutical CDMO & CMO - Formulation. Development. Commercialization		 200 yes 750 48
https://agnopharma.com/about/
About Agno Pharma: Your Trusted Global Partner In CDMO Solutions		 200 yes 1085 48
https://agnopharma.com/about/careers/
Agno Pharmaceuticals Careers		 200 yes 691 48
https://agnopharma.com/analytical-services/capabilities/ich-stability-programs/
ICH-Compliant Stability Programs: Following Strict Protocols For Testing & Storage Services		 200 yes 1096 48
https://agnopharma.com/category/blog/
The Agno Pharmaceuticals Blog And Technical Briefs		 200 yes 1142 54
https://agnopharma.com/contact-us/
Contact Agno Pharmaceuticals		 200 yes 580 48
https://agnopharma.com/drug-product/manufacturing/cgmp-commercial/
CGMP Clinical Manufacturing Compliant Pharma Lab And Storage Facility		 200 yes 726 48
https://agnopharma.com/implants-lais/rd/polymeric-cryomilling/
Polymeric Cryomilling Services Facility For Pharmaceutical Companies		 200 yes 705 48
https://agnopharma.com/intermediates-api/manufacturing/cgmp-commercial-manufacturing/
The Facility For CGMP Commercial API Manufacturing For Drug Products		 200 yes 814 48
https://agnopharma.com/event/podd-conference-boston-ma/
Join Agno Pharmaceuticals At PODD Conference		 200 yes 496 1
https://agnopharma.com/news/particle-sciences-inc-and-delaqua-pharmaceuticals-announce-strategic-collaboration/
Particle Sciences Inc. And DelAQUA Pharmaceuticals Announce Strategic Collaboration | Agno Pharmaceuticals		 200 yes 1104 2
https://agnopharma.com/technical-briefs/development-and-validation-of-in-vitro-release-testing-for-semisolid-formulations/
Development And Validation Of In Vitro Release Testing For Semisolid Formulations | Agno Pharmaceuticals		 200 yes 2049 2
https://agnopharma.com/technical-briefs/overview-of-the-zeta-potential/
Zeta Potential (ZP): An Overview And ZP Guide | Agno Pharmaceuticals		 200 yes 2325 2
https://agnopharma.com/technical-briefs/combination-devices/
Combination Devices: Production Processes, Biocompatibility Tests, Drug Release Profiles | Agno Pharmaceuticals		 200 yes 1915 2
https://agnopharma.com/technical-briefs/emulsions-and-emulsifications/
Emulsions And Emulsifications Methods And Processes | Agno Pharmaceuticals		 200 yes 2217 2
https://agnopharma.com/technical-briefs/potent-compound-handling-operations/
Potent Compound Handling Operations: Exposure To APIs | Agno Pharmaceuticals		 200 yes 1735 2
https://agnopharma.com/technical-briefs/process-analytical-technology/
Process Analytical Technology (PAT): Hot Melt Extrusion | Agno Pharmaceuticals		 200 yes 1942 2
https://agnopharma.com/blog/beta-lactam-manufacturing-challenges/
Beta-Lactam Manufacturing Challenges: How We Overcome Production Hurdles | Agno Pharmaceuticals		 200 yes 2035 1
https://agnopharma.com/blog/contract-pharmaceutical-manufacturing-industry-projections/
Contract Pharmaceutical Manufacturing Industry Projections: Insights From Dr. Robert W. Lee, 30-Year Veteran | Agno Pharmaceuticals		 200 yes 3019 1
https://agnopharma.com/blog/nanomilling-for-poorly-soluble-apis-the-mill-is-the-easy-part/
Nanomilling For Poorly Soluble APIs: The Mill Is The Easy Part | Agno Pharmaceuticals		 200 yes 2553 1
https://agnopharma.com/blog/scaling-up-pharmaceutical-production-for-successful-technology-transfer-in-sterile-dosage-forms/
Scaling Up Pharmaceutical Production For Successful Technology Transfer In Sterile Dosage Forms | Agno Pharmaceuticals		 200 yes 2467 1
https://agnopharma.com/blog/the-complete-guide-to-long-acting-injectable-lai-formulations/
The Complete Guide To Long-Acting Injectable (LAI) Formulations | Agno Pharmaceuticals		 200 yes 3720 1
https://agnopharma.com/blog/the-modern-cdmo/
Guide To The Modern CDMO: A Strategic Blueprint For Pharmaceutical Leaders | Agno Pharmaceuticals		 200 yes 3975 1
https://agnopharma.com/news/agno-pharma-acquires-actyliss-cdmo-manufacturing-asset/
Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, The Legacy Cascade Chemistry Business | Agno Pharmaceuticals		 200 yes 1037 1
https://agnopharma.com/news/robert-w-lee-ph-d-to-present-on-advanced-nanocrystal-technology-at-november-2025-formulation-summit/
Robert W. Lee, Ph.D., To Present On Advanced NanoCrystal Technology At November 2025 Formulation Summit | Agno Pharmaceuticals		 200 yes 1583 1
https://agnopharma.com/technical-briefs/considerations-in-particle-sizing-part-2-specifying-a-particle-size-analyzer/
Considerations In Particle Sizing - Part 2: Specifying A Particle Size Analyzer | Agno Pharmaceuticals		 200 yes 2384 1
https://agnopharma.com/technical-briefs/cubic-phase-particles/
Cubic Phase Particles In Drug Delivery - A Detailed Brief | Agno Pharmaceuticals		 200 yes 1682 1
https://agnopharma.com/technical-briefs/dissolution-testing-for-osd/
Dissolution Testing For OSD: Detect Physical Changes In API And The Formulated Product | Agno Pharmaceuticals		 200 yes 1717 1
https://agnopharma.com/technical-briefs/dissolving-films/
Dissolving Films: Film Manufacture, Solvent-Cast Films, Extruded Films | Agno Pharmaceuticals		 200 yes 1912 1
https://agnopharma.com/technical-briefs/emulsion-stability-and-testing/
Emulsion Stability And Testing | Agno Pharmaceuticals		 200 yes 2071 1
https://agnopharma.com/technical-briefs/encapsulation/
Encapsulation Methods And Properties Of Capsules | Agno Pharmaceuticals		 200 yes 1847 1
https://agnopharma.com/technical-briefs/glossary-of-polymer-terms/
Glossary Of Polymer Terms | Agno Pharmaceuticals		 200 yes 1892 1
https://agnopharma.com/technical-briefs/hot-melt-extrusion/
Hot Melt Extrusion - Drug Manufacturing | Twin Screw Extruders | Agno Pharmaceuticals		 200 yes 1809 1
https://agnopharma.com/technical-briefs/mechanical-dispersing-of-insoluble-apis/
Mechanical Dispersing Of Insoluble APIs | Agno Pharmaceuticals		 200 yes 2162 1
https://agnopharma.com/technical-briefs/phase-behavior-of-surface-active-solutes/
Phase Behavior Of Surface-Active Solutes | Agno Pharmaceuticals		 200 yes 2144 1
https://agnopharma.com/technical-briefs/protein-structure/
Protein Structure: Primary, Secondary, Tertiary, Quatemary Structures | Agno Pharmaceuticals		 200 yes 2267 1
https://agnopharma.com/technical-briefs/solid-solutions-and-dispersions/
Solid Solutions And Dispersions | Agno Pharmaceuticals		 200 yes 2068 1
https://agnopharma.com/technical-briefs/surfactants/
Surfactants: Micellization, Liquid Crystal Structures | Agno Pharmaceuticals		 200 yes 2065 1
https://agnopharma.com/technical-briefs/the-patent-process/
The Patent Process: Criteria, Timeline | Agno Pharmaceuticals		 200 yes 2521 1
https://agnopharma.com/about/team/celia-l-alexander/
Celia L. Alexander | Agno Pharmaceuticals		 200 yes 518 0
https://agnopharma.com/analytical-services/
Analytical Services From Agno Pharmaceuticals		 200 yes 417 0
https://agnopharma.com/analytical-services/capabilities/
Capabilities | Agno Pharmaceuticals		 200 yes 417 0
https://agnopharma.com/drug-product/
Drug Product Services Company		 200 yes 417 0
https://agnopharma.com/drug-product/dosage-forms/
Dosage Forms From Agno Pharmaceuticals		 200 yes 417 0
https://agnopharma.com/implants-lais/
Implants / LAIs Services Company		 200 yes 417 0
https://agnopharma.com/implants-lais/manufacturing/
Drug Manufacturing From Agno Pharmaceuticals		 200 yes 417 0
https://agnopharma.com/intermediates-api/
Intermediates, API, HPAPI, & Sterile API Supplier Company		 200 yes 417 0
https://agnopharma.com/intermediates-api/rd/
R And D Expertise From Agno Pharmaceuticals		 200 yes 417 0
https://agnopharma.com/locations.kml 200 no 0 0
https://agnopharma.com/wp-content/uploads/2025/10/PSI-white.svg 200 no 0 47

Audit your own site — free

157 checks, internal PageRank, render-diff. No signup, results in ~30s.

Scan your site →